Conference
|
Taiwan Trials 2013
26 February, 2013 - 27 February, 2013
Taipei, Taiwan
|
Taiwan Trials 2013 will be the ONLY focused clinical trial platform in Taiwan.
Why you should attend:
- Meet trial sponsors, CROs, hospitals and technology and solution
providers from Taiwan and elsewhere at this unique meeting platform to
build close relationships
- Keep updated with the most recent regulatory moves, strategic and technological innovation
- Gain insights into the current operations and future directions of
regional and global outsourcing in Taiwan from pioneers in the industry
- Understand the potential impacts and emerging opportunities on
regional trial operations arising from Taiwan-China regulatory
harmonisation
- Discuss and address strategies to overcome pressing challenges that specifically matters to conducting trials in Taiwan
|
|
Featured Speakers
|
|
|
Wim Swyzen,
Regional Vice President for Global Clinical Operations for Asia Pacific,
Janssen, Singapore
|
|
|
Ko-Chung Lin,
Founder and Chief Executive Officer,
PharmaEssentia, Taiwan
|
|
|
Catherine Yi-San Lee,
Executive Director, Area Head of Clinical Trials Support and Compliance Asia,
Pfizer Inc.
|
|
|
Gregory Liu,
Head of Medical Department, Oncology Business Unit,
TTY Biopharm, Taiwan
and Clinical Research Director,
TOT Biopharm, China
|
|
|
Distinguished Speaker Faculty Include:
|
Benjamin Ing-Tiau Kuo,
Chairperson,
Human Subject Protection Association, Taiwan
|
|
Carlos Linn,
Regional Medical Director, Oncology, Asia/China, Emerging Markets,
Pfizer Inc., China
|
|
Catherine Yi-San Lee,
Executive Director, Area Head of Clinical Trials Support and Compliance Asia,
Pfizer Inc.
|
|
|
Chin-Fu Hsiao,
Director of the Division of Clinical Trials Statistics,
National Health Research Institutes, Taiwan
|
|
Choo Beng Goh,
Medical Director,
GlaxoSmithKline, Taiwan
|
|
Churn Shiouh Gau,
Executive Director,
Center for Drug Evaluation, Taiwan
|
|
Chyong Huey Lai,
Chang Gung Memorial Hospital, Taiwan
|
|
Gregory Liu,
Head of Medical Department, Oncology Business Unit,
TTY Biopharm, Taiwan
and Clinical Research Director,
TOT Biopharm, China
|
|
Ho Jin Oh, Assistant Director, Clinical Trial Management Division, Food and Drug Administration, Korea |
|
|
Hui-Ling Shieh,
Medical Director,
Yung Shin Pharm Ind. Co., Taiwan
|
|
Hung Jen Lai,
Medical Director,
Merck Sharp and Dohme, Taiwan
|
|
James Garner,
Vice President and General Manager,
Takeda Global Research and Development Center (Asia), Singapore
|
|
|
Ko-Chung Lin,
Founder and Chief Executive Officer,
PharmaEssentia, Taiwan
|
|
Min-Hsiung Kao,
Clinical Operation Director,
Taiwan Liposome Company Ltd, Taiwan |
 |
Ming-Chu Hsu,
Founder, Chairman and CEO,
TaiGen Biotechnology, Taiwan |
 |
|
Rosalind Lu,
Asia-Pacific Regional Head for Roche Product Development Global Operation Country Clinical Operation,
Roche Pharmaceuticals, Taiwan
|
 |
Wim Swyzen,
Regional Vice President for Global Clinical Operations for Asia Pacific,
Janssen, Singapore |
|
Wing-Kai Chan,
Director,
National Clinical Trials and Research Center, National Taiwan Univeristy, Taiwan |
 |
|
Yoshiya Oda,
President of Biomarkers and Personalized Medicine Unit,
Eisai Inc., USA
|
 |
|
|
|
|
Sales and Marketing Opportunities at the ONLY clinical trials event in Taiwan
Your business is about much more than just knocking on doors. Your
marketing strategy is much more than a lead generator. To generate sales
in Taiwan, you need a Taiwan-oriented platform and genuine leadership
position. To generate awareness and response, you need targeted,
decision-maker focused, geographically effective marketing. To generate
profits, you need marketing service of Taiwan Trials 2013!
Taiwan Trials 2013 will give you the unique opportunity to
position your business in front of decision makers from Taiwan’s and the
region’s most progressive companies involved in pharmaceutical, biotech, clinical management, clinical data management, clinical supply and many more!
|
Choose your language
Media Partners
International Marketing Partner
Industry Event Calendar
|
